Press Releases August 5, 2026 04:20 PM

NLI HOLDINGS ANNOUNCES QUARTERLY DIVIDEND FOR THE THIRD QUARTER OF 2026 AT $.10 PER SHARE

NLI Holdings Declares Quarterly Dividend of $0.10 Per Share for Q3 2026

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
NL

NLI Holdings, Inc. announced that its board of directors has declared a quarterly dividend of $0.10 per share for the third quarter of 2026, payable on September 22, 2026 to shareholders of record as of September 3, 2026. The company operates in the security products, recreational marine components, and chemical (TiO2) sectors.

NLI HOLDINGS ANNOUNCES QUARTERLY DIVIDEND FOR THE THIRD QUARTER OF 2026 AT $.10 PER SHARE
NL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • NLI Holdings declared a $0.10 per share quarterly dividend for Q3 2026.
  • The dividend is payable on September 22, 2026, for shareholders of record as of September 3, 2026.
  • The company operates in security products, recreational marine components, and titanium dioxide (TiO2) chemical businesses.

Dallas, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- NLI Holdings, Inc. (NYSE: NL) today announced that its board of directors has declared a quarterly dividend of ten cents ($0.10) per share on its common stock, payable on September 22, 2026 to stockholders of record at the close of business on September 3, 2026. 

NLI Holdings, Inc. is engaged in the component products (security products and recreational marine components) and chemicals (TiO2) businesses.

* * * * *

Investor Relations Contact

Bryan A. Hanley
Senior Vice President and Treasurer
Tel. 972-233-1700


Risks

  • Dividend payments depend on future earnings and cash flow, which may fluctuate.
  • Exposure to fluctuating demand in components and chemical industries could impact profitability.
  • Economic conditions affecting the security, marine, and chemical sectors could influence company performance.

More from Press Releases

BCB Bancorp, Inc. Announces Pricing of Common Stock Offering Sep 16, 2026 Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling Sep 16, 2026 Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS) Sep 16, 2026 XTEND Selected as Gauntlet II Top Performer in $1 Billion U.S. Drone Dominance Program Sep 16, 2026 CVB Financial Corp. Announces 148th Consecutive Quarterly Cash Dividend Sep 16, 2026